Higgs Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 M
as on 08-12-2024
- Paid Up Capital ₹ 0.50 M
as on 08-12-2024
- Company Age 4 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 12.00 Cr
as on 08-12-2024
- Revenue %
(FY 2022)
- Profit -1728.22%
(FY 2022)
- Ebitda -984.76%
(FY 2022)
- Net Worth
- Total Assets 6618.95%
(FY 2022)
About Higgs Life Sciences
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹12.00 Cr.
Parveen Kumar, Gautam Madhok, Alok Madhok, and One other member serve as directors at the Company.
- CIN/LLPIN
U24290CH2019PTC042848
- Company No.
042848
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Dec 2019
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chandigarh
Industry
Company Details
- Location
Chandigarh, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Higgs Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Parveen Kumar  | Director | 30-Dec-2019 | Current |
| Gautam Madhok | Director | 30-Dec-2019 | Current |
| Alok Madhok | Director | 30-Dec-2019 | Current |
| Manav Arora | Director | 30-Dec-2019 | Current |
Financial Performance and Corporate Structure Insights of Higgs Life Sciences.
Higgs Life Sciences Private Limited, for the financial year ended 2022, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 1728.22% decrease in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth | |||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Higgs Life Sciences?
Unlock access to Higgs Life Sciences's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Higgs Healthcare Private LimitedActive 6 years 2 monthsGautam Madhok and Alok Madhok are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Feb 2022 | ₹12.00 Cr | Open |
How Many Employees Work at Higgs Life Sciences?
Unlock and access historical data on people associated with Higgs Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Higgs Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Higgs Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
